{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:45:31Z","timestamp":1779324331603,"version":"3.51.4"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014107","name":"Stichting TSC Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Neuronal excitation-inhibition (E\/I) imbalances are considered an important pathophysiological mechanism in neurodevelopmental disorders. Preclinical studies on tuberous sclerosis complex (TSC), suggest that altered chloride homeostasis may impair GABAergic inhibition and thereby E\/I-balance regulation. Correction of chloride homeostasis may thus constitute a treatment target to alleviate behavioral symptoms. Recently, we showed that bumetanide\u2014a chloride-regulating agent\u2014improved behavioral symptoms in the open-label study Bumetanide to Ameliorate Tuberous Sclerosis Complex Hyperexcitable Behaviors trial (BATSCH trial; Eudra-CT: 2016-002408-13). Here, we present resting-state EEG as secondary analysis of BATSCH to investigate associations between EEG measures sensitive to network-level changes in E\/I balance and clinical response to bumetanide. EEGs of 10 participants with TSC (aged 8\u201321 years) were available. Spectral power, long-range temporal correlations (LRTC), and functional E\/I ratio (<jats:italic>f<\/jats:italic>E\/I) in the alpha-frequency band were compared before and after 91 days of treatment. Pre-treatment measures were compared against 29 typically developing children (TDC). EEG measures were correlated with the Aberrant Behavioral Checklist-Irritability subscale (ABC-I), the Social Responsiveness Scale-2 (SRS-2), and the Repetitive Behavior Scale-Revised (RBS-R). At baseline, TSC showed lower alpha-band absolute power and <jats:italic>f<\/jats:italic>E\/I than TDC. Absolute power increased through bumetanide treatment, which showed a moderate, albeit non-significant, correlation with improvement in RBS-R. Interestingly, correlations between baseline EEG measures and clinical outcomes suggest that most responsiveness might be expected in children with network characteristics around the E\/I balance point. In sum, E\/I imbalances pointing toward an inhibition-dominated network are present in TSC. We established neurophysiological effects of bumetanide although with an inconclusive relationship with clinical improvement. Nonetheless, our results further indicate that baseline network characteristics might influence treatment response. These findings highlight the possible utility of E\/I-sensitive EEG measures to accompany new treatment interventions for TSC.<\/jats:p><jats:sec><jats:title>Clinical Trial Registration<\/jats:title><jats:p>EU Clinical Trial Register, EudraCT 2016-002408-13 (<jats:ext-link>www.clinicaltrialsregister.eu\/ctr-search\/trial\/2016-002408-13\/NL<\/jats:ext-link>). Registered 25 July 2016.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2022.879451","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T13:43:38Z","timestamp":1652363018000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study"],"prefix":"10.3389","volume":"16","author":[{"given":"Erika L.","family":"Juarez-Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorinde M.","family":"van Andel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.","family":"Sprengers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur-Ervin","family":"Avramiea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"Oranje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floortje E.","family":"Scheepers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floor E.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibert D.","family":"Mansvelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Linkenkaer-Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilgo","family":"Bruining","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13229-020-0320-2","article-title":"Recent advances in human stem cell-based modeling of tuberous sclerosis complex.","volume":"11","author":"Afshar Saber","year":"2020","journal-title":"Mol. Autism."},{"key":"B2","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.","volume":"89","author":"Aman","year":"1985","journal-title":"Am. J. Ment. Defic."},{"key":"B3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13311-013-0251-0","article-title":"Epilepsy related to developmental tumors and malformations of cortical development.","volume":"11","author":"Aronica","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"107754","DOI":"10.1016\/j.neuropharm.2019.107754","article-title":"Functional characterization of novel bumetanide derivatives for epilepsy treatment.","volume":"162","author":"Auer","year":"2020","journal-title":"Neuropharmacology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e53016","DOI":"10.7554\/eLife.53016","article-title":"Pre-stimulus phase and amplitude regulation of phase-locked responses are maximized in the critical state.","volume":"9","author":"Avramiea","year":"2020","journal-title":"eLife"},{"key":"B6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.neuron.2013.03.017","article-title":"Excitatory\/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.","volume":"78","author":"Bateup","year":"2013","journal-title":"Neuron"},{"key":"B7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","article-title":"NKCC1 chloride importer antagonists attenuate many neurological and psychiatric disorders.","volume":"40","author":"Ben-Ari","year":"2017","journal-title":"Trends Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuroimage.2004.06.016","article-title":"Superior temporal sulcus anatomical abnormalities in childhood autism: a voxel-based morphometry MRI study.","volume":"23","author":"Boddaert","year":"2004","journal-title":"Neuroimage"},{"key":"B9","author":"Britton","year":"2016","journal-title":"Electroencephalography (EEG): An Introductory Text and Atlas of Normal and Abnormal Findings in Adults, Children, and Infants."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1038\/s41598-020-65500-4","article-title":"Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics.","volume":"10","author":"Bruining","year":"2020","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.clinph.2011.09.012","article-title":"Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-na\u00efve epilepsy patients.","volume":"123","author":"Cho","year":"2012","journal-title":"Clin. Neurophysiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/a:1025014929212","article-title":"Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised.","volume":"33","author":"Constantino","year":"2003","journal-title":"J. Autism Dev. Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2014.10.028","article-title":"Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.","volume":"52","author":"Curatolo","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis.","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/dmcn.15073","article-title":"Evolution of electroencephalogram in infants with tuberous sclerosis complex and neurodevelopmental outcome: a prospective cohort study.","volume":"64","author":"De Ridder","year":"2021","journal-title":"Dev. Med. Child Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"582891","DOI":"10.3389\/fneur.2020.582891","article-title":"Prediction of neurodevelopment in infants with tuberous sclerosis complex using Early EEG characteristics.","volume":"11","author":"De Ridder","year":"2020","journal-title":"Front. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nurt.2010.05.001","article-title":"Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex.","volume":"7","author":"de Vries","year":"2010","journal-title":"Neurotherapeutics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","article-title":"Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist.","volume":"52","author":"de Vries","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"102145","DOI":"10.1016\/j.nicl.2019.102145","article-title":"Linking alpha oscillations, attention and inhibitory control in adult ADHD with EEG neurofeedback.","volume":"25","author":"Deiber","year":"2020","journal-title":"Neuroimage Clin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/S1355617709090481","article-title":"Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders.","volume":"15","author":"Dennis","year":"2009","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/aur.2193","article-title":"Early patterns of functional brain development associated with autism spectrum disorder in tuberous sclerosis complex.","volume":"12","author":"Dickinson","year":"2019","journal-title":"Autism Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41593-020-00744-x","article-title":"Parameterizing neural power spectra into periodic and aperiodic components.","volume":"23","author":"Donoghue","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ana.21229","article-title":"Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.","volume":"63","author":"Dzhala","year":"2008","journal-title":"Ann. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1111\/j.1528-1167.2012.03654.x","article-title":"Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy.","volume":"54","author":"Eftekhari","year":"2013","journal-title":"Epilepsia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1093\/cercor\/bhr300","article-title":"GABAergic interneuron development and function is modulated by the Tsc1 gene.","volume":"22","author":"Fu","year":"2012","journal-title":"Cereb Cortex."},{"key":"B26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ana.20597","article-title":"Autism severity and temporal lobe functional abnormalities.","volume":"58","author":"Gendry Meresse","year":"2005","journal-title":"Ann. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40263-019-00607-5","article-title":"A preliminary study evaluating the safety and efficacy of bumetanide, an NKCC1 inhibitor, in patients with drug-resistant epilepsy.","volume":"33","author":"Gharaylou","year":"2019","journal-title":"CNS Drugs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13229-020-00340-7","article-title":"Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working memory in mice.","volume":"11","author":"Haji","year":"2020","journal-title":"Mol. Autism."},{"key":"B29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3389\/fphys.2012.00450","article-title":"Detrended fluctuation analysis: a scale-free view on neuronal oscillations.","volume":"3","author":"Hardstone","year":"2012","journal-title":"Front. Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pediatrneurol.2016.03.010","article-title":"Recent advances in resting-state electroencephalography biomarkers for autism spectrum disorder-a review of methodological and clinical challenges.","volume":"61","author":"Heunis","year":"2016","journal-title":"Pediatric. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"775172","DOI":"10.3389\/fphys.2021.775172","article-title":"STXBP1 syndrome is characterized by inhibition-dominated dynamics of resting-state EEG.","volume":"12","author":"Houtman","year":"2021","journal-title":"Front. Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/WCO.0000000000000181","article-title":"Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders.","volume":"28","author":"Jeste","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2021.08.009","article-title":"Prediction of behavioral improvement through resting-state EEG and clinical severity in a randomized controlled trial testing bumetanide in autism spectrum disorder.","author":"Juarez-Martinez","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging."},{"key":"B34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.pediatrneurol.2013.12.002","article-title":"Mechanism-based treatment in tuberous sclerosis complex.","volume":"50","author":"J\u00fclich","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/0883073809333526","article-title":"Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1.","volume":"24","author":"Kahle","year":"2009","journal-title":"J. Child Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fnins.2019.00310","article-title":"Off-Label use of bumetanide for brain disorders: an overview.","volume":"13","author":"Kharod","year":"2019","journal-title":"Front. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nphys289","article-title":"Optimal dynamical range of excitable networks at criticality.","volume":"2","author":"Kinouchi","year":"2006","journal-title":"Nat. Phys."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1111\/j.1528-1167.2010.02730.x","article-title":"Low-grade focal cortical dysplasia is associated with prenatal and perinatal brain injury.","volume":"51","author":"Krsek","year":"2010","journal-title":"Epilepsia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/acn3.494","article-title":"Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders.","volume":"4","author":"Krueger","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.yebeh.2011.02.021","article-title":"Power spectral analysis in infants with seizures: relationship to development.","volume":"20","author":"Kulandaivel","year":"2011","journal-title":"Epilepsy Behav."},{"key":"B42","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10803-006-0213-z","article-title":"The repetitive behavior scale-revised: independent validation in individuals with autism spectrum disorders.","volume":"37","author":"Lam","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"B43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/YCO.0000000000000136","article-title":"Advances in the treatment of tuberous sclerosis complex.","volume":"28","author":"Leclezio","year":"2015","journal-title":"Curr. Opin. Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1038\/tp.2012.124","article-title":"A randomised controlled trial of bumetanide in the treatment of autism in children.","volume":"2","author":"Lemonnier","year":"2012","journal-title":"Trans. Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1056","DOI":"10.1038\/tp.2017.10","article-title":"Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.","volume":"7","author":"Lemonnier","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1523\/JNEUROSCI.21-04-01370.2001","article-title":"Long-range temporal correlations and scaling behavior in human brain oscillations.","volume":"21","author":"Linkenkaer-Hansen","year":"2001","journal-title":"J. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","article-title":"Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments.","volume":"69","author":"L\u00f6scher","year":"2013","journal-title":"Neuropharmacology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fncom.2018.00023","article-title":"On the physiological modulation and potential mechanisms underlying parieto-occipital alpha oscillations.","volume":"12","author":"Lozano-Soldevilla","year":"2018","journal-title":"Front. Comput. Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.cub.2014.10.017","article-title":"GABAergic modulation of visual gamma and alpha oscillations and its consequences for working memory performance.","volume":"24","author":"Lozano-Soldevilla","year":"2014","journal-title":"Curr. Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/nm.3987","article-title":"Treatment during a vulnerable developmental period rescues a genetic epilepsy.","volume":"21","author":"Marguet","year":"2015","journal-title":"Nat. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/cercor\/bhl049","article-title":"Epileptogenic neocortical networks are revealed by abnormal temporal dynamics in seizure-free subdural EEG.","volume":"17","author":"Monto","year":"2007","journal-title":"Cereb Cortex."},{"key":"B52","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.braindev.2011.09.001","article-title":"Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex.","volume":"34","author":"Mori","year":"2012","journal-title":"Brain Dev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.stemcr.2018.11.019","article-title":"Neuron-Glia interactions increase neuronal phenotypes in tuberous sclerosis complex patient iPSC-Derived models.","volume":"12","author":"Nadadhur","year":"2019","journal-title":"Stem Cell Reports."},{"key":"B54","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","article-title":"Excitatory\/Inhibitory balance and circuit homeostasis in autism spectrum disorders.","volume":"87","author":"Nelson","year":"2015","journal-title":"Neuron"},{"key":"B55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 iinternational tuberous sclerosis complex consensus conference.","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/brain\/123.9.1838","article-title":"Abnormal regional cerebral blood flow in childhood autism.","volume":"123","author":"Ohnishi","year":"2000","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","article-title":"A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex.","volume":"93","author":"Overwater","year":"2019","journal-title":"Neurology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tins.2007.02.001","article-title":"New vistas for alpha-frequency band oscillations.","volume":"30","author":"Palva","year":"2007","journal-title":"Trends Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1063\/1.166141","article-title":"Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series.","volume":"5","author":"Peng","year":"1995","journal-title":"Chaos"},{"key":"B60","doi-asserted-by":"publisher","first-page":"9817","DOI":"10.1523\/JNEUROSCI.5990-11.2012","article-title":"Critical-state dynamics of avalanches and oscillations jointly emerge from balanced excitation\/inhibition in neuronal networks.","volume":"32","author":"Poil","year":"2020","journal-title":"J. Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/08830738040190090601","article-title":"Behavioral and cognitive aspects of tuberous sclerosis complex.","volume":"19","author":"Prather","year":"2004","journal-title":"J. Child Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/epi.12620","article-title":"Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures.","volume":"55","author":"Puskarjov","year":"2014","journal-title":"Epilepsia"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e206653","DOI":"10.1001\/jamanetworkopen.2020.6653","article-title":"Evaluation of a machine learning model based on pretreatment symptoms and electroencephalographic features to predict outcomes of antidepressant treatment in adults with depression: a prespecified secondary analysis of a randomized clinical trial.","volume":"3","author":"Rajpurkar","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clinph.2020.10.020","article-title":"Measuring the effects of first antiepileptic medication in temporal lobe epilepsy: predictive value of quantitative-EEG analysis.","volume":"132","author":"Ricci","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","article-title":"Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions.","volume":"95","author":"Ruffolo","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.conb.2012.04.008","article-title":"Targeted treatment trials for tuberous sclerosis and autism: no longer a dream.","volume":"22","author":"Sahin","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s10548-017-0588-5","article-title":"Long-Range temporal correlations reflect treatment response in the electroencephalogram of patients with infantile spasms.","volume":"30","author":"Smith","year":"2017","journal-title":"Brain Topogr."},{"key":"B68","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jaac.2020.07.888","article-title":"Bumetanide for core symptoms of autism spectrum disorder (BAMBI): a single center, double-blinded, participant-randomized, placebo-controlled, Phase-2 superiority trial.","volume":"60","author":"Sprengers","year":"2020","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa1307491","article-title":"Patches of disorganization in the neocortex of children with autism.","volume":"370","author":"Stoner","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neuroimage.2009.05.060","article-title":"High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI Instrument.","volume":"47","author":"Taki","year":"2009","journal-title":"Neuroimage"},{"key":"B71","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.22696","article-title":"Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.","volume":"71","author":"Talos","year":"2012","journal-title":"Ann. Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1528-1167.2010.02918.x","article-title":"Interictal regional delta slowing is an EEG marker of epileptic network in temporal lobe epilepsy.","volume":"52","author":"Tao","year":"2011","journal-title":"Epilepsia"},{"key":"B73","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.eplepsyres.2010.05.005","article-title":"The slow-wave component of the interictal epileptiform EEG discharges.","volume":"90","author":"Terney","year":"2010","journal-title":"Epilepsy Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e39127","DOI":"10.1371\/journal.pone.0039127","article-title":"Developmental trajectories of resting EEG power: an endophenotype of autism spectrum disorder.","volume":"7","author":"Tierney","year":"2012","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrn1327","article-title":"Homeostatic plasticity in the developing nervous system.","volume":"5","author":"Turrigiano","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1247190","article-title":"Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring.","volume":"343","author":"Tyzio","year":"2014","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13229-020-00335-4","article-title":"Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.","volume":"11","author":"van Andel","year":"2020","journal-title":"Mol. Autism."},{"key":"B78","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fneur.2017.00469","article-title":"Bumetanide as a candidate treatment for behavioral problems in tuberous sclerosis complex.","volume":"8","author":"Vlaskamp","year":"2017","journal-title":"Front. Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1866-1955-5-24","article-title":"Resting state EEG abnormalities in autism spectrum disorders.","volume":"5","author":"Wang","year":"2013","journal-title":"J. Neurodev. Disord."},{"key":"B80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.21058","article-title":"Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1.","volume":"61","author":"Wang","year":"2007","journal-title":"Ann. Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/1531-8249(200101)49:1<67::aid-ana10>3.0.co;2-l","article-title":"Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers.","volume":"49","author":"White","year":"2001","journal-title":"Ann. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41587-019-0397-3","article-title":"An electroencephalographic signature predicts antidepressant response in major depression.","volume":"38","author":"Wu","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"B83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41398-020-0692-2","article-title":"Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA\/glutamate ratios.","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e1918377","DOI":"10.1001\/jamanetworkopen.2019.18377","article-title":"Use of machine learning for predicting escitalopram treatment outcome from electroencephalography recordings in adult patients with depression.","volume":"3","author":"Zhdanov","year":"2020","journal-title":"JAMA Netw. Open"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.879451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T13:43:46Z","timestamp":1652363026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.879451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":84,"alternative-id":["10.3389\/fnins.2022.879451"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.879451","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"article-number":"879451"}}